Improvements in cholesterol efflux capacity of HDL and adiponectin contribute to mitigation in cardiovascular disease risk after bariatric surgery in a cohort with morbid obesity.

Thakkar, Himani; Vincent, Vinnyfred; Shukla, Sakshi; Sra, Manraj; Kanga, Uma; Aggarwal, Sandeep; Singh, Archna

Thakkar, Himani; Vincent, Vinnyfred; Shukla, Sakshi; Sra, Manraj; Kanga, Uma; Aggarwal, Sandeep; Singh, Archna.

Afiliação

Thakkar H; Department of Biochemistry, All India Institute of Medical Sciences, Room No. 3044, New Delhi, 110029, India.
Vincent V; Department of Biochemistry, All India Institute of Medical Sciences, Room No. 3044, New Delhi, 110029, India.
Shukla S; Department of Biochemistry, All India Institute of Medical Sciences, Room No. 3044, New Delhi, 110029, India.
Sra M; All India Institute of Medical Sciences, New Delhi, India.
Kanga U; Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi, India.
Aggarwal S; Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Singh A; Department of Biochemistry, All India Institute of Medical Sciences, Room No. 3044, New Delhi, 110029, India. arch_singh@ymail.com.

Diabetol Metab Syndr ; 13(1): 46, 2021 Apr 17.

Article em En | MEDLINE | ID: mdl-33865458

Palavras-chave

Adiponectin; Bariatric surgery; Cardiovascular risk; Cholesterol efflux capacity; Dyslipidemia; Insulin resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google